New biopsy method aims to cut unnecessary prostate cancer diagnoses

NCT ID NCT07296042

Not yet recruiting Diagnosis Sponsor: Ramsay Générale de Santé Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways of taking prostate biopsies in men with suspected prostate cancer. The new method takes samples from the MRI-visible spot and nearby areas, while the standard method also samples random spots across the prostate. The goal is to see if the new approach catches dangerous cancers just as well but finds fewer harmless ones, reducing overdiagnosis and anxiety. About 456 men will take part across multiple centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

CHI Mont de Marsan - Site de Layné

Mont-de-Marsan, 40024, France
CHU de Bordeaux

Bordeaux, 33000, France
Clinique La Croix du Sud - RAMSAY Santé

Quint-Fonsegrives, 31130, France
Hôpital Nord, Assistance Publique des Hôpitaux de Marseille

Marseille, 13015, France
Hôpital privé des Peupliers - Ramsay Santé

Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.